Skip to main content
Clinical Trials/NCT03789409
NCT03789409UnknownNot Applicable

Intermittent Fasting Following Acute Ischemic Stroke: Prospective, Randomized, Parallel Group, Controlled Trial

Ulsan University Hospital1 site in 1 country68 target enrollmentStarted: March 4, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
68
Locations
1
Primary Endpoint
Change of Surface electromyography

Study Overview

Brief Summary

Despite numerous kinds of evidence on functional health and CNS protection of intermittent fasting after injuries were found in many brain-, and spinal cord-damaged animal models, there has yet to be any clinical study of intermittent fasting after acute ischemic cerebral infarction. The aim of this study is to evaluate the neurological, functional and clinical efficacy of intermittent fasting in patients after acute ischemic stroke.

Detailed Description

In order to verify the validity and clinical efficacy of intermittent fasting for neurological and functional effects of ischemic cerebral infarction, the first ischemic stroke (diagnosed within 1 year through brain MRI / CT) patients will be randomly assigned to intermittent fasting group or control group. In both groups, physical therapy, occupational therapy and speech therapy will be provided during 3 hours in total a day. The intermittent fasting group should maintain intermittent fasting for no less than 12 hours or more every day during the rehabilitation period (at least 1 week), and the control group is able to eat all of the hospital meals and all the participants want without any time limit. The efficacy of intermittent fasting is to be verified by performing the electro-physiological tests and functional evaluations before participation, 1st week, 2nd weeks after participation, before discharge, 3 months, and 6 months after the stroke onset.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients who was diagnosed first ischemic stroke within preceeding 1 year through brain MRI/CT

Exclusion Criteria

  • •Musculo-skeletal disease with limbs malformation or joint contracture
  • •Weigh more than 135 kg or taller than 195 cm
  • •Diabetes mellitus
  • •unstable patient in neurology
  • •Refusal of participation

Arms & Interventions

Intermittent Fasting

Experimental

Over rehabilitation treatment during and admission (at least 1 week), intermittent fasting (IF) for more than 12 hours (water can be allowed). For subgroup assignment, participants can choose IF1 (eat early in the evening and late in the morning) or Post-IF2 (eat the remaining two meals without breakfast), depending on own their faver.

Intervention: Intermittent Fasting (Dietary Supplement)

Ad libitium

No Intervention

Participants will be allowed to have hospital meals and all the desired intake without time limit.

Outcomes

Primary Outcomes

Change of Surface electromyography

Time Frame: 1 day before the initiation of intervention, and 6 months after the stroke onset

root mean square and root peak square of compound motor action potential

Secondary Outcomes

  • Change of Korean-modified Barthel index(1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chang Ho Hwang

Associate Professor

Ulsan University Hospital

Study Sites (1)

Loading locations...

Similar Trials